Skip to main content

Soluble Thrombomodulin

BRD ID: 2041
Tier: SOP
Source: TCP Project
Number of times downloaded: 711

Description

This document describes the protocol used by the Pathology and Laboratory Medicine Department of Boston Medical Center (BMC) to quantify levels of soluble thrombomodulin (sTM) in plasma by ELISA as part of the Thrombosis in Cancer Patients (TCP) Project. It is a product of the Center for Strategic Scientific Initiatives (CSSI) of the National Institutes of Health (NIH) (https://www.cancer.gov/about-nci/organization/cssi/research/past-programs#thrombosis-in-cancer-standardization-of-biomarker-measurements).